「la」の検索結果
367件：11～15件目を表示
-
千寿製薬株式会社
新闻 2025年09月04日 Senju has developed and obtained approval for a BAC-free formulation of Aibeta® combination eye drops（PDF） 2025年03月07日 Announcement of Licensing Agreement with Brill International（PDF） ...
https://www.senju.co.jp/chinese/ -
NewMytear CL Cool Hi-s | OTC Products, etc. | Products | SENJU Pharmaceutical
ffered from the following symptom: Severe eye pain Persons diagnosed with the following condition: Glaucoma 2. Stop using this medicine immediately and consult a physician, pharmacist, or registered s...
http://www.senju.co.jp/english/products/clcoolhi-s.html -
NewMytear CL Cool-s | OTC Products, etc. | Products | SENJU Pharmaceutical
ffered from the following symptom: Severe eye pain Persons diagnosed with the following condition: Glaucoma 2. Stop using this medicine immediately and consult a physician, pharmacist, or registered s...
https://www.senju.co.jp/english/products/clcool-s.html -
产品开发方针 | 研究与开发 | 千寿制药株式会社
得到必要的治疗。并且报告中还提到白内障、屈光不正（近视、老花眼等）、老年性黄斑变性、青光眼、糖尿病性视网膜病变等是导致全球性视力受损或失明的主要原因。 为创造针对眼部疾病的高价值（First in Class、Best in Class、提升患者便利性等）的产品，今后，我们也将全力推进研究开发活动。我们从“对导致视力受损或失明的眼部疾病的贡献”、“满足未满足的医疗需求*”、“商业化的可能性”的角度...
http://www.senju.co.jp/chinese/rd/policy/ -
NewMytear CL-s | OTC Products, etc. | Products | SENJU Pharmaceutical
ffered from the following symptom: Severe eye pain Persons diagnosed with the following condition: Glaucoma 2. Stop using this medicine immediately and consult a physician, pharmacist, or registered s...
https://www.senju.co.jp/english/products/cl-s.html